Nervgen Pharma NGEN
NASDAQ NGEN
$1.78 +0.02 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Interest & Investment Income (2025 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Interest & Investment Income of -$130,452 in the quarter ended Jun 30, 2026, compared with -$62,720 a year earlier.

Analysis

Nervgen Pharma (NGEN) Interest & Investment Income (2025 - 2026) Analysis & Trends

On a TTM basis, Nervgen Pharma's Interest & Investment Income came in at -$193,957 as of Jun 30, 2026; for the year ended Dec 31, 2025, it was -$238,632.

  • Across earlier years, Interest & Investment Income came in at -$593,535 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Nervgen Pharma 141.78 Mn 141.78 Mn - -130,451.87
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -130,451.87
Mar 31, 2026 -75,886.25
Jun 30, 2025 -62,719.70
Mar 31, 2025 75,100.42
API Access

Nervgen Pharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NGEN&period=max&api_key=YOUR_API_KEY